New Incisionless Robotic Head and Neck Cancer Surgery Without Scarring

A new incisionless robotic surgical procedure has been developed by Doctors which will allow the removal of head and neck cancer tumours without visible scarring.

A new incisionless robotic surgical procedure has been developed by Doctors which will allow the removal of head and neck cancer tumours without visible scarring or affecting speech.

Henry Ford Hospital in Detroit is one of the first in the country to perform TransOral Robotic Surgery (TORS) using the da Vinci Surgical System.

Treatment For Head and Neck Tumors Benefited With High-dosage Brachytherapy
Researchers at the University of Navarra Hospital say that high-dosage perioperative brachytherapy can prove very useful in the treatment of head and neck tumours, and for reducing

Unlike traditional surgical approaches to head and neck cancer, TORS patients are able to return to their normal lives only a few days after surgery without significant pain and disfigurement.

"TORS offers shorter post-operative recovery than standard open surgical approaches, giving patients the opportunity to quickly and successfully return to their normal lives," said Tamer A. Ghanem of the Henry Ford Hospital.

"TORS allows surgeons to completely remove tumours of the head and neck while preserving speech, swallowing, and other key quality of life issues such as eating. There also is no visible scaring or disfigurement," he said.

Indonesian boy with huge neck tumor was surgically removed
4.41 lb weighed tumor of the neck caused due to Iodine deficiency an endemic problem in Sumba diet.

The hospital has performed more than a dozen TORS procedures since the U.S. Food and Drug Administration approved it in January.

"So far it has been used to remove malignant and benign tumours of the mouth, tongue, tonsils, and parts of the throat.

Allergic Reaction to Cancer Drug in the Middle Southern U.S. Puzzles Scientists
A recent study have identified an unusually high rate of allergic reaction in cancer patients living in the middle South who received a common drug used for treating their cancer.

"Surgeons operate with greater precision and control using the TORS approach minimizing the pain, and reducing the risk of possible nerve and tissue damage associated with large incisions," said Ghanem.

Source-ANI

Glaxo Files Cancer Drug For Approval With FDA
Tykerb has been filed for approval with FDA and European regulators to test its efficacy against neck and head tumors.